Onderneming InMed Pharmaceuticals Inc. Toronto S.E.
Aandelen
IN
CA4576376012
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 13
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
BayMedica
100,0
%
| 1 | 100,0 % | 4 | 100,0 % | +279,61% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 4 | 100,0 % | +279,61% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Chief Operating Officer | - | 05-11-18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Gerard Griffin
SAM | Sales & Marketing | - | 01-02-22 |
Eric Hsu
PRN | Corporate Officer/Principal | - | 13-03-18 |
General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11-02-22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16-06-16 |
Andrew Hull
CHM | Chairman | 61 | 12-09-16 |
Bryan Baldasare
BRD | Director/Board Member | 58 | 12-05-22 |
Nicole Lemerond
BRD | Director/Board Member | 48 | 08-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 137 034 | 14 054 505 ( 99,42 %) | 0 | 99,42 % |
Bedrijfsgegevens
InMed Pharmaceuticals, Inc.
815 West Hastings Street Suite 310
V6C 1B4, Vancouver
+604 669 7207
http://www.inmedpharma.com![Adres InMed Pharmaceuticals Inc.(IN)](https://cdn.zonebourse.com/static/address/42503446.png)
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,26% | 121 mld. | |
+17,22% | 110 mld. | |
+17,99% | 25,98 mld. | |
-24,01% | 19,27 mld. | |
-18,54% | 15,99 mld. | |
-18,62% | 15,66 mld. | |
-48,32% | 14,5 mld. | |
+57,53% | 14,47 mld. | |
+3,79% | 13,91 mld. |